SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of the American Psychiatric Nurses Association
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Littrell, K. H.
Right arrow Articles by Littrell, S. H.
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Emerging Applications of Newer Antipsychotic Agents in Specific Patient Populations

Kimberly H. Littrell, APRN, CS

The Promedica Research Center in Tucker, Georgia

Steven H. Littrell, MA, LPC

The Fielding Institute in Santa Barbara, California

Conventional neuroleptics have been the mainstay of treatment for patients with schizo phrenia for many years. The mechanism of action of these drugs has long been accept ed and their side effects well documented. With the recent introduction of newer antipsy chotics such as clozapine, risperidone, and olanzapine, a new generation of medications has become available whose pharmacologic properties are just beginning to be realized. These newer antipsychotics appear to be superior to conventional neuroleptics in treat ing patients with schizophrenia. Because of their reduced neurotoxicity, the newer antipsychotics may be particularly beneficial in treating psychosis in specific putient populations. This review presents preliminary findings on the use of the newer antipsy chotics for treating psychosis in five patient populations: children and adolescents with schizophrenia and other psychotic disorders; first-episode schizophrenia; dual diagno sis ; bipolar disorder; and elderly patients. Because of the expanded utilities of the newer antipsychotics, psychiatric nurses should be familiar with all available treatment options. (J Am Psychiatr Nurses Assoc [1998]. 4, S42-S52.)

Journal of the American Psychiatric Nurses Association, Vol. 4, No. 4, S42-S52 (1998)
DOI: 10.1177/107839039800400409
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




Advertisement